Latin Labs Private Limited
About Latin Labs Private Limited
Data last updated:
Latin Labs Private Limited is a private limited company based in Villupuram, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 May 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85100TN2012PTC085924. Its GSTIN is 33AACCL2707Q1ZD (Tamil Nadu).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹37.2 Lakh. It is led by directors including Meena and Ganapathy Rajaraman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 15/3 Govindasamy Pillai Street Kilperumbakkam, Villupuram, Tamil Nadu, India – 605602.
As per the financials filed for FY 2024, the company reported a revenue of ₹5 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹13.32 Lakh (net margin 2.7%) and EBITDA of ₹18.09 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Latin Labs Private Limited's registered office is in Villupuram, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered Address15/3 Govindasamy Pillai Street Kilperumbakkam, Villupuram, Tamil Nadu, India – 605602
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Latin Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Latin Labs is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Latin Labs Private Limited, buy the company report.
Financials of Latin Labs Private Limited
FY 2025 filings availableLatin Labs Private Limited reported revenue of ₹5 Cr (up 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 3% growth in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Latin Labs Private Limited, buy the company report.
Board of directors of Latin Labs Private Limited
Latin Labs has 18 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meena | Director | 30 Mar 2015 | 11 Years 6 Months | Current |
| Ganapathy Rajaraman | Director | 16 May 2012 | 14 Years 5 Months | Current |
| Pramila Devi | Director | 16 May 2012 | 14 Years 5 Months | Current |
| Mustaqali Sheikabdulkader | Director | 30 Mar 2015 | 11 Years 6 Months | Current |
| Usha Gopalakrishnan | Director | 16 May 2012 | 14 Years 5 Months | Current |
| Sengadhasan Sittharthan | Director | 30 Mar 2015 | 11 Years 6 Months | Current |
Peer comparison
Latin Labs Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abs Services (India) Private Limited | ₹5 Cr (FY 2024) | 77.0% | Meerut, Uttar Pradesh, India | |||
| Miot Medical Supplies Private Limited | ₹5 Cr (FY 2024) | -55.0% | Chennai, Tamil Nadu, India | |||
| Latin Labs Private Limitedthis company | ₹5 Cr (FY 2024) | ₹13.32 Lakh | 2.7% | 3.0% | Villupuram, Tamil Nadu, India | |
| Shree Medicine Traders Private Limited | ₹4.99 Cr (FY 2025) | 9.0% | Hoshiarpur, Punjab, India |
To see the full peer comparison of Latin Labs Private Limited, buy the company report.
Shareholding
The shareholding of Latin Labs Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Latin Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Latin Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Latin Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Latin Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AACCL2707Q1ZD | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Latin Labs Private Limited, buy the company report.
Recent activity
Latin Labs Private Limited has 18 board changes on record since 2012: 18 appointments. The latest: Dhanasekar was appointed as Director on 30 Mar 2015.
9 earlier events are in the company report.
Frequently asked questions
Latin Labs is an active private limited company based in Villupuram, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 May 2012 (14+ years old) and is registered under CIN U85100TN2012PTC085924.
Latin Labs has 18 current directors:
- Meena - Director
- Ganapathy Rajaraman - Director
- Pramila Devi - Director
- Mustaqali Sheikabdulkader - Director
- Usha Gopalakrishnan - Director
- Sengadhasan Sittharthan - Director
- Santhi Tamilarasu - Director
- Anandha Krishnan Venkatraman - Director
- Govindarajan Madhiyazhagan - Director
- Jayaraman Ganesh - Director
- Bhuvaneswari - Director
- Dhanasekar - Director
- Poovarasi Sivakkumar - Director
- Muthukumar Kala - Director
- Gurjala Kirupanandam - Director
- Anbarasan Puvimathi - Director
- Saravanaraja - Director
- Dhamodharan - Director
The latest financial statements of Latin Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Latin Labs is 33AACCL2707Q1ZD, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Latin Labs is U85100TN2012PTC085924. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Latin Labs was incorporated on 16 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Latin Labs by revenue are Abs Services (India) Private Limited, Miot Medical Supplies Private Limited, Shree Medicine Traders Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (retail trading).
Dhanasekar was appointed as Director on 30 Mar 2015. Govindarajan Madhiyazhagan was appointed as Director on 30 Mar 2015. Jayaraman Ganesh was appointed as Director on 30 Mar 2015. Latin Labs has 18 board changes on record in total.
The registered office of Latin Labs is at 153 Govindasamy Pillai Street Kilperumbakkam, Villupuram, Tamil Nadu, India – 605602.
Latin Labs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Latin Labs is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.